SCHEMBL10180593

SCHEMBL10180593

CCCC(=O)Oc1cc(F)c(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.47
ALDH1A1 P00352 2/20 0.40
BCL9 O00512 1/20 0.39
CTNNB1 P35222 1/20 0.39
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
LMNA P02545 1/20 0.38
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
RAB9A P51151 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27915961 0.89 KMT2A (0.50) ALOX15KMT2AKDM4EMEN1RECQL
SCHEMBL27789372 0.86 ALOX15 (0.43) ALOX15ALDH1A1BCL9CTNNB1KMT2A
SCHEMBL10181392 0.85 ALOX15 (0.45) ALOX15KMT2AKDM4ERECQLLMNA
SCHEMBL10179983 0.82 ALOX15 (0.45) ALOX15ALDH1A1BCL9CTNNB1KMT2A
SCHEMBL2003095 0.81 ALOX15 (0.51) ALOX15BCL9CTNNB1KMT2AKDM4E
SCHEMBL2001222 0.81 ALOX15 (0.48) ALOX15BCL9CTNNB1KMT2AKDM4E
SCHEMBL27917198 0.80 CYP4F2 (0.41) ALDH1A1LMNACYP4F2CYP4A11RAB9A
SCHEMBL6907595 0.80 CYP4F2 (0.37) ALDH1A1KMT2AKDM4EMEN1LMNA
SCHEMBL2000685 0.79 ALOX15 (0.41) ALOX15ALDH1A1BCL9CTNNB1KMT2A
SCHEMBL27579984 0.79 ALOX15 (0.40) ALOX15ALDH1A1BCL9CTNNB1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109896980-A A kind of biological synthesis method of sitagliptin intermediate 浙江九洲药业股份有限公司 2019-06-18 CN claimed
CN-105254519-B Synthesizing method of sitagliptin key intermediate 常州吉恩药业有限公司 2017-05-17 CN claimed
CN-109896980-A A kind of biological synthesis method of sitagliptin intermediate 浙江九洲药业股份有限公司 2019-06-18 CN disclosed
CN-109824546-A BOC- (R) -3- amino -4- (2,4,5- trifluorophenyl) butyric acid is condensed impurity and preparation method thereof 浙江永太科技股份有限公司 2019-05-31 CN disclosed
CN-109721555-A Acylated piperazine class compound and application thereof 广东东阳光药业有限公司 2019-05-07 CN disclosed
CN-105331651-B The enzyme-chemically preparation method of sitagliptin and its intermediate 尚科生物医药(上海)有限公司 2018-11-13 CN disclosed
CN-106478460-B A kind of synthetic method of chirality N-Boc-3- amino -4- aryl-butyric acid 衢州学院 2018-06-12 CN disclosed
CN-106478460-A A kind of synthetic method of 3 amino of chirality N Boc, 4 aryl butyric acid 衢州学院 2017-03-08 CN disclosed
CN-102574856-B The synthesis of sitagliptin 基因里克斯(英国)有限公司 2016-09-21 CN disclosed
CN-103483340-B A kind of synthetic method of sitagliptin 无锡佰翱得生物科学有限公司 2016-09-07 CN disclosed
CN-104159886-A Preparation of optically pure beta-amino acid active pharmaceutical ingredients and intermediates thereof LEK PHARMACEUTICALS 2014-11-19 CN disclosed
CN-104112870-A Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same MITSUBISHI CHEM CORP 2014-10-22 CN disclosed
US-20130244122-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME ONUKI MASAMICHI (JP) 2013-09-19 US disclosed
US-20120219866-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 US disclosed
EP-2475041-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME Mitsubishi Chemical Corporation (JP) 2012-07-11 EP disclosed